{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:10:02Z","timestamp":1790309402117,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"publisher","award":["IG17276"],"award-info":[{"award-number":["IG17276"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000030","name":"IG","doi-asserted-by":"publisher","award":["23116"],"award-info":[{"award-number":["23116"]}],"id":[{"id":"10.13039\/501100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007076","name":"FIRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FUV Fellowship"},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009882","name":"Regione Lombardia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.canlet.2020.09.027","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T11:18:07Z","timestamp":1601983087000},"page":"84-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis"],"prefix":"10.1016","volume":"496","author":[{"given":"Elisabetta","family":"Grillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosetta","family":"Ravelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"di Somma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Zammataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Presta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Mitola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5275","key":"10.1016\/j.canlet.2020.09.027_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.273.5275.595","article-title":"Mapping the protein universe","volume":"273","author":"Holm","year":"1996","journal-title":"Science"},{"issue":"5626","key":"10.1016\/j.canlet.2020.09.027_bib2","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1126\/science.1085371","article-title":"Evolution of the protein repertoire","volume":"300","author":"Chothia","year":"2003","journal-title":"Science"},{"issue":"D1","key":"10.1016\/j.canlet.2020.09.027_bib3","doi-asserted-by":"crossref","first-page":"D427","DOI":"10.1093\/nar\/gky995","article-title":"The Pfam protein families database in 2019","volume":"47","author":"El-Gebali","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.canlet.2020.09.027_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cels.2015.08.014","article-title":"Pan-cancer analysis of mutation hotspots in protein domains","volume":"1","author":"Miller","year":"2015","journal-title":"Cell Syst"},{"issue":"D1","key":"10.1016\/j.canlet.2020.09.027_bib5","doi-asserted-by":"crossref","first-page":"D986","DOI":"10.1093\/nar\/gkv1132","article-title":"MutationAligner: a resource of recurrent mutation hotspots in protein domains in cancer","volume":"44","author":"Gauthier","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2020.09.027_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12859-016-0935-7","article-title":"LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer","volume":"17","author":"Melloni","year":"2016","journal-title":"BMC Bioinf."},{"issue":"15","key":"10.1016\/j.canlet.2020.09.027_bib7","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1158\/1078-0432.CCR-18-0103","article-title":"Exome sequencing of plasma DNA portrays the mutation landscape of colorectal cancer and discovers mutated VEGFR2 receptors as modulators of antiangiogenic therapies","volume":"24","author":"Toledo","year":"2018","journal-title":"Clin. Canc. Res."},{"issue":"1","key":"10.1016\/j.canlet.2020.09.027_bib8","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1038\/s41598-017-06366-x","article-title":"Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types","volume":"7","author":"Kumar","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2020.09.027_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-018-0782-4","article-title":"Mechanisms of receptor tyrosine kinase activation in cancer","volume":"17","author":"Du","year":"2018","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2020.09.027_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pharmthera.2017.02.006","article-title":"Targeting TRK family proteins in cancer","volume":"173","author":"Khotskaya","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.canlet.2020.09.027_bib11","article-title":"KDR mutation as a novel predictive biomarker of exceptional response to regorafenib in metastatic colorectal cancer","volume":"8","author":"Loaiza-Bonilla","year":"2016","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.canlet.2020.09.027_bib12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jamadermatol.2017.0187","article-title":"Clinical response to pazopanib in a patient with KDR-mutated metastatic basal cell carcinoma","volume":"153","author":"Knepper","year":"2017","journal-title":"Jama Dermatology"},{"issue":"7","key":"10.1016\/j.canlet.2020.09.027_bib13","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006502","article-title":"Signal transduction by vascular endothelial growth factor receptors","volume":"2","author":"Koch","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.canlet.2020.09.027_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5322-0","article-title":"VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer","volume":"19","author":"Lian","year":"2019","journal-title":"BMC Canc."},{"issue":"4","key":"10.1016\/j.canlet.2020.09.027_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10456-019-09676-y","article-title":"VEGFR2 activation mediates the pro-angiogenic activity of BMP4","volume":"22","author":"Rezzola","year":"2019","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.canlet.2020.09.027_bib16","doi-asserted-by":"crossref","first-page":"16700","DOI":"10.1038\/s41598-017-16786-4","article-title":"Multi-physics interactions drive VEGFR2 relocation on endothelial cells","volume":"7","author":"Damioli","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.canlet.2020.09.027_bib17","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.4049\/jimmunol.171.7.3725","article-title":"IL-12 regulates an endothelial cell-lymphocyte network: effect on metalloproteinase-9 production","volume":"171","author":"Mitola","year":"2003","journal-title":"J. Immunol."},{"issue":"24","key":"10.1016\/j.canlet.2020.09.027_bib18","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1038\/s41388-018-0171-x","article-title":"Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations","volume":"37","author":"Dankner","year":"2018","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.canlet.2020.09.027_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091311","article-title":"The impact of Flt3 gene mutations in acute promyelocytic leukemia: a meta-analysis","volume":"11","author":"Picharski","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.canlet.2020.09.027_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1532\/IJH97.06071","article-title":"Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutation","volume":"83","author":"Kiyoi","year":"2006","journal-title":"Int. J. Hematol."},{"issue":"suppl_1","key":"10.1016\/j.canlet.2020.09.027_bib21","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/annonc\/mdx702","article-title":"Overview of current systemic management of EGFR-mutant NSCLC","volume":"29","author":"Hsu","year":"2018","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2020.09.027_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/17476348.2017.1267569","article-title":"New data on clinical decisions in NSCLC patients with uncommon EGFR mutations","volume":"11","author":"Wu","year":"2017","journal-title":"Expet Rev. Respir. Med."},{"issue":"23","key":"10.1016\/j.canlet.2020.09.027_bib23","doi-asserted-by":"crossref","first-page":"e2086","DOI":"10.1212\/WNL.0000000000005658","article-title":"FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas","volume":"90","author":"Picca","year":"2018","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.canlet.2020.09.027_bib24","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/hmg\/10.12.1255","article-title":"Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice","volume":"10","author":"Iwata","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.canlet.2020.09.027_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fcell.2015.00004","article-title":"The regulation of MMP targeting to invadopodia during cancer metastasis","volume":"3","author":"Jacob","year":"2015","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.canlet.2020.09.027_bib26","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ijc.31745","article-title":"The metastatic microenvironment: melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells","volume":"144","author":"Izraely","year":"2019","journal-title":"Int. J. Canc."},{"issue":"1","key":"10.1016\/j.canlet.2020.09.027_bib27","doi-asserted-by":"crossref","first-page":"9377","DOI":"10.1038\/s41598-020-65927-9","article-title":"Feature selection strategies for drug sensitivity prediction","volume":"10","author":"Koras","year":"2020","journal-title":"Sci. Rep."},{"issue":"10151","key":"10.1016\/j.canlet.2020.09.027_bib28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Melanoma. Lancet"},{"issue":"52","key":"10.1016\/j.canlet.2020.09.027_bib29","doi-asserted-by":"crossref","first-page":"21113","DOI":"10.1073\/pnas.1310559110","article-title":"FLT3\/D835Y mutation knock-in mice display less aggressive disease compared with FLT3\/internal tandem duplication (ITD) mice","volume":"110","author":"Bailey","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.canlet.2020.09.027_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/157488707780599320","article-title":"Implications of FLT3 mutations in the therapy of acute myeloid leukemia","volume":"2","author":"Mattison","year":"2007","journal-title":"Rev. Recent Clin. Trials"},{"issue":"11","key":"10.1016\/j.canlet.2020.09.027_bib31","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1158\/1078-0432.CCR-10-3408","article-title":"Effectiveness of tyrosine kinase inhibitors on \"uncommon\" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer","volume":"17","author":"Wu","year":"2011","journal-title":"Clin. Canc. Res."},{"issue":"7","key":"10.1016\/j.canlet.2020.09.027_bib32","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood-2010-06-289959","article-title":"KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib","volume":"118","author":"Gleixner","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.canlet.2020.09.027_bib33","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/35073068","article-title":"Studying protein dynamics in living cells","volume":"2","author":"Lippincott-Schwartz","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.canlet.2020.09.027_bib34","first-page":"1867","article-title":"Molecular insight on the altered membrane trafficking of TrkA kinase dead mutants","author":"Amodeo","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"1","key":"10.1016\/j.canlet.2020.09.027_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12943-018-0801-5","article-title":"Advances in studies of tyrosine kinase inhibitors and their acquired resistance","volume":"17","author":"Jiao","year":"2018","journal-title":"Mol. Canc."},{"issue":"21","key":"10.1016\/j.canlet.2020.09.027_bib36","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"33","key":"10.1016\/j.canlet.2020.09.027_bib37","doi-asserted-by":"crossref","first-page":"14903","DOI":"10.1073\/pnas.1008990107","article-title":"The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner","volume":"107","author":"Joseph","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520304973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520304973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:52:05Z","timestamp":1759593125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383520304973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":37,"alternative-id":["S0304383520304973"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2020.09.027","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2020.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}